(FM) Cardiología y Cirugía Cardiovascular
Departamento académico
University of Milan
Milán, ItaliaPublicaciones en colaboración con investigadores/as de University of Milan (11)
2024
-
Comparison of assays measuring extracellular vesicle tissue factor in plasma samples: communication from the ISTH SSC Subcommittee on Vascular Biology
Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 10, pp. 2910-2921
-
Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study
Nature Medicine, Vol. 30, Núm. 7, pp. 2020-2029
-
Stroke in critically ill patients with respiratory failure due to COVID-19: Disparities between low-middle and high-income countries
Heart and Lung, Vol. 68, pp. 131-144
2022
-
Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EORP atrial fibrillation general long-term registry
European Journal of Internal Medicine, Vol. 99, pp. 45-56
-
Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry
BMC Medicine, Vol. 20, Núm. 1
-
Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry
Europace, Vol. 24, Núm. 5, pp. 721-728
-
Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis
Critical Care, Vol. 26, Núm. 1
-
Impact of malignancy on outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EURObservational research programme in atrial fibrillation general long-term registry
European Journal of Clinical Investigation, Vol. 52, Núm. 7
2021
2007
-
A worldwide perspective of atypical pathogens in community-acquired pneumonia
American Journal of Respiratory and Critical Care Medicine, Vol. 175, Núm. 10, pp. 1086-1093
2004
-
Different effects of antihypertensive therapies based on losartan or atenolol on ultrasound and biochemical markers of myocardial fibrosis: Results of a randomized trial
Circulation, Vol. 110, Núm. 5, pp. 552-557